*Division of Surgery, Department Surgery and Cancer, Imperial College London, United Kingdom †St Mark's Hospital and Academic Institute, Harrow, United Kingdom.
Ann Surg. 2017 Nov;266(5):847-853. doi: 10.1097/SLA.0000000000002387.
To study the influence of esophageal cancer surgeon volume upon mortality from upper gastrointestinal emergencies.
Volume-outcome relationships led to the centralization of esophageal cancer surgery.
Hospital Episode Statistics data were used to identify patients admitted to hospitals within England (1997-2012). The influence of esophageal high-volume (HV) cancer surgeon status (≥5 resections per year) upon 30-day and 90-day mortality from esophageal perforation (EP), paraesophageal hernia causing obstruction or gangrene (PEH) and perforated peptic ulcer (PPU) was analyzed, independent of HV esophageal cancer center status and patient and disease-specific confounding factors.
A total of 3707, 12,411, and 57,164 patients with EP, PEH, and PPU, respectively, were included. The observed 90-day mortality was 36.5%, 11.5%, and 29.0% for EP, PEH, and PPU, respectively.Management by HV cancer surgeon was independently associated with significant reductions in 30-day and 90-day mortality from EP (odds ratio, OR 0.51, 95% confidence interval, CI, 0.40-0.66), PEH (OR=0.70, 95% CI 0.53-0.91), and PPU (OR=0.85, 95% CI 0.7-0.95). Subset analysis of those patients receiving primary surgery as treatment showed no change in mortality when performed by HV cancer surgeons.However HV cancer surgeons performed surgery as primary treatment more commonly for EP (OR=2.38, 95% CI 1.87-3.04) and PEH (OR=2.12, 95% CI 1.79-2.51). Furthermore surgery was independently associated with reduced mortality for all 3 conditions.
The complex elective workload of HV esophageal cancer surgeons appears to lower the threshold for surgical intervention in specific upper gastrointestinal emergencies such as EP and PEH, which in turn reduces mortality.
研究食管癌外科医生手术量对上消化道急症死亡率的影响。
手术量-结局关系促使食管癌手术集中化。
利用英格兰医院入院病例统计数据(1997-2012 年),确定接受治疗的患者。分析高手术量(HV)食管癌外科医生(每年手术量≥5 例)对食管穿孔(EP)、食管旁疝伴梗阻或坏疽(PEH)和穿透性溃疡(PPU)患者 30 天和 90 天死亡率的影响,同时考虑 HV 食管癌中心状态和患者及疾病特异性混杂因素的影响。
纳入 EP、PEH 和 PPU 患者分别为 3707 例、12411 例和 57164 例。观察到 EP、PEH 和 PPU 的 90 天死亡率分别为 36.5%、11.5%和 29.0%。由 HV 食管癌外科医生治疗与 EP(比值比,OR=0.51,95%置信区间,CI,0.40-0.66)、PEH(OR=0.70,95%CI,0.53-0.91)和 PPU(OR=0.85,95%CI,0.7-0.95)患者 30 天和 90 天死亡率的显著降低独立相关。对接受初次手术治疗的患者进行亚组分析显示,由 HV 食管癌外科医生治疗并未改变死亡率。然而,HV 食管癌外科医生更常对 EP(OR=2.38,95%CI,1.87-3.04)和 PEH(OR=2.12,95%CI,1.79-2.51)患者进行初次手术治疗。此外,手术对所有 3 种情况的死亡率降低均具有独立相关性。
HV 食管癌外科医生复杂的择期手术工作量似乎降低了 EP 和 PEH 等特定上消化道急症进行手术干预的门槛,从而降低了死亡率。